S
Shigeki Momohara
Researcher at Keio University
Publications - 229
Citations - 8288
Shigeki Momohara is an academic researcher from Keio University. The author has contributed to research in topics: Rheumatoid arthritis & Arthritis. The author has an hindex of 39, co-authored 224 publications receiving 7380 citations. Previous affiliations of Shigeki Momohara include Rush University Medical Center.
Papers
More filters
Journal ArticleDOI
Recent Orthopedic Surgeries Aiming to Improve Quality of Life for Patients with Rheumatoid Arthritis.
TL;DR: The authors suggest that recent dramatic improvements in medical treatment might explain the reduction in numbers of orthopedic joint surgeries, which also suggests that there is a worldwide trend toward improved longterm outcomes.
Journal ArticleDOI
Reparative radiological changes of the hip joint in rheumatoid arthritis: do these findings indicate the true repair of the joint?
TL;DR: It is illustrated that when acing an isolated lytic bone lesion in a patient with a myeloproiferative syndrome, in addition to screen for a primary known eoplasm, localized MS transformation could be suspected, even n absence of evocative cell count signs of transformation into eukaemia.
Journal ArticleDOI
Does Abatacept Increase Postoperative Adverse Events in Rheumatoid Arthritis Compared with Conventional Synthetic Disease-modifying Drugs?
Hiromu Ito,Shigeyoshi Tsuji,Masanori Nakayama,Yuichi Mochida,Keiichiro Nishida,Hajime Ishikawa,Toshihisa Kojima,Takumi Matsumoto,Ayako Kubota,Takeshi Mochizuki,Koji Sakuraba,Isao Matsushita,Arata Nakajima,Ryota Hara,Akihisa Haraguchi,Tsukasa Matsubara,Katsuaki Kanbe,Natsuko Nakagawa,Masahide Hamaguchi,Shigeki Momohara +19 more
TL;DR: Compared with csDMARD and/or steroids without ABA, adding ABA to the treatment does not appear to increase the incidence rates of postoperative AE in patients with RA undergoing orthopedic surgery.
Journal ArticleDOI
Long-term outcome of 114 adult JIA patients in a non-pediatric rheumatology institute in Japan.
Takako Miyamae,Eiichi Tanaka,Takayuki Kishi,Tsuyoshi Matsuyama,Tohru Igarashi,Satoshi Fujikawa,Atsuo Taniguchi,Shigeki Momohara,Hisashi Yamanaka +8 more
TL;DR: Patients with more recent disease onset showed an improved outcome and establishing and sharing a transition program among pediatric and non-pediatric rheumatologists is desirable.
Journal ArticleDOI
Assessment of the effectiveness of golimumab 50-mg and 100-mg regimens in patients with rheumatoid arthritis in daily practice
Eri Sato,Eiichi Tanaka,Ayako Nakajima,Eisuke Inoue,Y. Shimizu,R. Yamaguchi,Moeko Ochiai,Kumi Shidara,Daisuke Hoshi,Naoki Sugimoto,Yohei Seto,Atsuo Taniguchi,Shigeki Momohara,Hisashi Yamanaka +13 more
TL;DR: Both GLM 50-mg and 100-mg regimens are effective in patients with rheumatoid arthritis in daily practice.